SB
Live price temporarily unavailable.
Price history
Sbc Medical Group Holdings Inc (SBC) is a Health Care company in the Russell 2000. Latest news and coverage below.
IPO: August 5, 2022 · $10.00 offering · NASDAQ · View IPO details →
Sbc Medical Group Holdings Inc revenue & net income history (FY2023–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|
| Income statement | |||
| Revenue | $193.5M | $205.4M | $173.6M |
| Growth (year over year) | — | +6.1% | −15.5% |
| Gross profit | $137.3M | $156.1M | $127.3M |
| Gross margin | 70.9% | 76.0% | 73.3% |
| Operating income | $70.7M | $70.3M | $67.5M |
| Operating margin | 36.5% | 34.2% | 38.9% |
| Net income | $39.4M | $46.6M | $51.0M |
| Net margin | 20.3% | 22.7% | 29.4% |
| EPS (diluted) | $0.42 | $0.48 | $0.50 |
| Balance sheet | |||
| Cash and equivalents | $103.0M | $125.0M | $163.8M |
| Total assets | $258.8M | $266.1M | $380.4M |
| Total liabilities | $115.0M | $71.1M | $117.1M |
| Long-term debt | — | $6.60M | $42.8M |
| Shareholders' equity | $142.2M | $195.1M | $248.3M |
| Cash flow | |||
| Operating cash flow | $50.7M | $20.6M | $24.7M |
| Capital expenditure | $8.54M | $2.56M | $1.40M |
| Free cash flow | $42.1M | $18.0M | $23.3M |
| Share buybacks | — | $0 | $5.00M |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $53.1M | $44.4M | $47.3M | $43.4M | $43.4M | $39.6M | $43.1M | $49.2M |
| Growth (year over year) | +12.3% | −28.8% | −13.6% | −18.3% | −18.3% | −10.9% | −9.0% | +13.4% |
| Gross profit | $43.2M | $33.9M | $37.7M | $30.0M | $30.6M | $28.9M | $30.3M | $36.0M |
| Gross margin | 81.5% | 76.3% | 79.7% | 69.2% | 70.6% | 73.1% | 70.5% | 73.1% |
| Operating income | $13.8M | $4.72M | $24.2M | $14.6M | $15.9M | $12.8M | $17.7M | $19.0M |
| Operating margin | 26.1% | 10.6% | 51.1% | 33.6% | 36.6% | 32.5% | 41.2% | 38.5% |
| Net income | $2.83M | $6.54M | $21.5M | $2.46M | $12.8M | $14.2M | $11.3M | $10.7M |
| Net margin | 5.3% | 14.7% | 45.4% | 5.7% | 29.6% | 35.9% | 26.3% | 21.7% |
| EPS (diluted) | $0.03 | $0.05 | $0.21 | $0.02 | $0.12 | $0.15 | $0.11 | $0.10 |
| Balance sheet | ||||||||
| Cash and equivalents | $137.4M | $125.0M | $132.1M | $152.7M | $127.4M | $163.8M | $167.3M | $184.3M |
| Total assets | $296.5M | $266.1M | $284.6M | $315.3M | $321.4M | $380.4M | $388.0M | $406.7M |
| Total liabilities | $91.0M | $71.1M | $58.3M | $70.6M | $73.3M | $117.1M | $117.6M | $126.7M |
| Long-term debt | $823.2K | $6.60M | $6.86M | $7.10M | $21.1M | $42.8M | $40.4M | $37.8M |
| Shareholders' equity | $205.0M | $195.1M | $226.4M | $244.6M | $248.0M | $248.3M | $255.3M | $263.8M |
| Cash flow | ||||||||
| Operating cash flow | $5.01M | −$7.30M | $1.93M | −$8.34M | −$20.9M | $52.0M | $9.23M | $22.5M |
| Capital expenditure | $409.0K | $590.4K | $253.7K | $306.7K | $43.1K | $797.5K | $125.0K | $84.4K |
| Free cash flow | $4.60M | −$7.89M | $1.67M | −$8.65M | −$20.9M | $51.2M | $9.11M | $22.4M |
| Share buybacks | — | $0 | — | — | $2.58M | $0 | — | — |
From Sbc Medical Group Holdings Inc's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About Sbc Medical Group Holdings Inc
- Headquarters
- Irvine, California From SEC filings, Oct 2026
Recent News (4)
-
NuxGame Returns from SBC Summit Lisbon 2026 with a Clear Read on Operator Plans for 2027 Sweepstakes launches, API-delivered content and multi-rail payments led the agenda at the NuxGame networking lounge at SBC Summit Lisbon 2026 LIMASSOL, Cyprus, Oct. 14, 2026 /PRNewswire/ -- B2B iGamin…
-
SBC Medical to Present at Cantor Fitzgerald Hong Kong’s Inaugural Asia Longevity Forum Yuya Yoshida, Director, CFO, and COO of SBC, will speak at Cantor Fitzgerald Hong Kong’s inaugural Asia Longevity Forum
-
Aitech Introduces New C165 Rugged Single Board Computer to Help Defense Programs Build and Modernize Fielded VME Systems New 6U VME SBC Delivers Modern Intel Computing and Graphics, SWaP Optimization and Secure High-Capacity Storage While Preserving Existing Infrastructure and Reducing Modernization Risk NATIONAL HARBOR…
-
More Health Care stocks
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- ALNY Alnylam Pharmaceuticals
- AMGN Amgen
- BAX Baxter International